Whether the given data are consistent with the fact that taurine exerts negative feedback on the release of vasopressin from the pituitary gland of the rat, and the reason behind the answer. The taurine released from pituitary gland over an hour, in the presence of vasopressin, is recorded in the following graph: Introduction: The pituitary gland is a part of the endocrine system that releases regulatory hormones. The two parts of pituitary gland secrete different types of hormones, for example, the growth hormone, prolactin, corticotrophin, and others. The anterior part of the pituitary gland releases vasopressin and the oxytocin hormones, which are almost similar in length to amino acids.

Question

Want to see the full answer?

Answer 1

Question

Chapter 38, Problem 1ITD

Summary Introduction

To review:

Whether the given data are consistent with the fact that taurine exerts negative feedback on the release of vasopressin from the pituitary gland of the rat, and the reason behind the answer. The taurine released from pituitary gland over an hour, in the presence of vasopressin, is recorded in the following graph:

Introduction:

The pituitary gland is a part of the endocrine system that releases regulatory hormones. The two parts of pituitary gland secrete different types of hormones, for example, the growth hormone, prolactin, corticotrophin, and others. The anterior part of the pituitary gland releases vasopressin and the oxytocin hormones, which are almost similar in length to amino acids.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

6) Consider the mechanism of net NaCl secretion across an epithelium shown below (in attachment) What provides the driving force for Cl- entry through the basolateral membrane into cell?

Vascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis. Based on this background, please answer the following questions If you wanted to measure the kinase activity of VEGFR-2, what are some of the conventional methods/assays you would use?

Vascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis. Based on this background, please answer the following questions How would you apply a TR-FRET assay to measure the in vitro kinase activity of VEGFR-2? Describe in steps the assay design and potential readout outcome.